Breast Biopsy Devices Market Size - By Product (Needle Based Breast Biopsy Guns, Breast Biopsy Guidance Systems, Needle, & Forceps), Technique (Image Guided Biopsy, Liquid Biopsy), End-use

Description

Breast Biopsy Devices Market size is estimated to record a CAGR of over 6.8% between 2023 and 2032, driven by the increasing incidence of breast cancer across the globe propelling the demand for advanced diagnostic technologies. As per NBCC, in 2023, around 297,790 new cases of invasive breast cancer were diagnosed in women, and 2,800 new cases diagnosed in men.

As awareness campaigns and screening programs become more prevalent, healthcare providers prioritize the incorporation of sophisticated biopsy devices to enhance the efficiency and precision of breast cancer diagnosis.

The development of minimally invasive techniques, such as vacuum-assisted biopsy and ultrasound-guided biopsy, reduces patient discomfort and procedural complications, leading to increased adoption. Moreover, innovations in imaging technologies and the integration of artificial intelligence (AI) for image interpretation contribute to higher diagnostic accuracy, stimulating the market growth.

The overall breast biopsy devices market is classified on the basis of product, technique, end-use, and region.

Liquid biopsy segment is poised for a notable growth during 2023 and 2032, backed by introduction of non-invasive and highly sensitive diagnostic methods. This innovative approach involves analyzing circulating tumor DNA (ctDNA) or other biomarkers present in the blood to detect and monitor various cancers. The technique complements traditional tissue biopsies, offering a less invasive alternative for monitoring treatment responses and identifying genetic mutations. The early detection capabilities, along with the real-time monitoring of disease progression is pushing the adoption of liquid biopsy.

Ambulatory surgical centers (ASCs) will generate notable revenues for the market during 2023-2032, favored by streamlined and efficient environment for performing breast biopsies. The focused nature of ambulatory surgical centers allows for quicker patient turnaround, reduced waiting times, and optimized scheduling, contributing to increased procedural efficiency. Moreover, patients often prefer ASCs for breast biopsy procedures due to the convenience, personalized care, and cost-effectiveness.

Europe breast biopsy devices industry size is slated to witness a significant growth through 2032, owing to the increasing prevalence of breast cancer and the continuous efforts to enhance early detection. The emphasis on women's health and robust medical infrastructure is leading to a widespread incorporation of sophisticated breast biopsy devices. Technological advancements, such as the integration of imaging technologies and minimally invasive biopsy techniques, further stimulate regional market growth by improving diagnostic accuracy and patient experience.

Product Code: 7441

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global breast biopsy devices market 360 degree synopsis, 2018 - 2032
- 2.1.1 Regional trends
- 2.1.2 Product trends
- 2.1.3 Technique trends
- 2.1.4 End-use trends

Chapter 3 Breast Biopsy Devices Industry Insights

3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Increasing incidence of breast cancer
  - 3.5.1.2 Technological advancements in breast biopsy equipment
  - 3.5.1.3 Rising awareness regarding breast cancer screening
  - 3.5.1.4 Favourable reimbursement scenario
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 High cost associated with breast biopsy procedure
  - 3.5.2.2 Risk of infection associated with the use of biopsy needles
3.6 Growth potential analysis
- 3.6.1 By product
- 3.6.2 By technique
- 3.6.3 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
- 4.1.1 Hologic Inc
- 4.1.2 Devicor Medical Products, Inc. (Danaher Corporation)
- 4.1.3 Becton, Dickinson and Company (BD)
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022

Chapter 5 Breast Biopsy Devices Market Size and Forecast, By Product, 2018-2032 (USD Million & Units)

5.1 Key trends, by product
5.2 Breast biopsy guidance systems
- 5.2.1 Manual
- 5.2.2 Robotic
5.3 Needle based breast biopsy guns
- 5.3.1 Vacuum-assisted biopsy (VAB) devices
- 5.3.2 Fine needle aspiration biopsy (FNAB) devices
- 5.3.3 Core needle biopsy (CNB) devices
5.4 Breast biopsy needles
- 5.4.1 Disposable
- 5.4.2 Reusable
5.5 Breast biopsy forceps
- 5.5.1 General biopsy forceps
- 5.5.2 Hot biopsy forceps
5.6 Other products
- 5.6.1 Brushes
- 5.6.2 Curettes
- 5.6.3 Punches

Chapter 6 Breast Biopsy Devices Market Size and Forecast, By Technique, 2018-2032 (USD Million)

6.1 Key trends, by technique
6.2 Image guided biopsy
- 6.2.1 MRI guided breast biopsy
- 6.2.2 Ultrasound guided breast biopsy
- 6.2.3 Mammography guided stereotactic biopsy
- 6.2.4 Other image guided biopsies
6.3 Liquid Biopsy
- 6.3.1 NGS based biopsy
- 6.3.2 PCR based biopsy
- 6.3.3 Micro-array based biopsy

Chapter 7 Breast Biopsy Devices Market Size and Forecast, By End-use, 2018-2032 (USD Million)

7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users

Chapter 8 Breast Biopsy Devices Market Size and Forecast, By Region, 2018-2032 (USD Million & Units)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

9.1 Stryker Corporation
9.2 Boston Scientific Corporation
9.3 FUJIFILM Holdings Corporation
9.4 Argon Medical Devices, Inc
9.5 Hologic Inc
9.6 Cook Group Incorporated
9.7 Becton, Dickinson and Company (BD)
9.8 Medtronic plc
9.9 Olympus Corporation
9.10 Cardinal Health
9.11 INRAD Inc
9.12 Danaher Corporation
9.13 B. Braun Melsungen AGS

Breast Biopsy Devices Market Size - By Product (Needle Based Breast Biopsy Guns, Breast Biopsy Guidance Systems, Needle, & Forceps), Technique (Image Guided Biopsy, Liquid Biopsy), End-use - Global Forecast (2023-2032)